Chinese clinical-stage biopharma firm Connect files for Nasdaq IPO

Chinese clinical-stage biopharma firm Connect files for Nasdaq IPO

Laboratory equipment. Photo: Pixabay

Connect Biopharma, a loss-making clinical-stage biopharmaceutical firm, based in China, has filed for an initial public offering (IPO) to raise up to $100 million on Nasdaq.